• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.29%

    MiMedx Group, Inc. (MDXG)

    8.62 0.08(0.92%) Jan 26, 4:00PM EST
    Add to Portfolio
    ProfileGet Profile for:
    MiMedx Group, Inc.
    1775 West Oak Commons Court, NE
    Marietta, GA 30062
    United States - Map
    Phone: 678-384-6720
    Website: http://www.mimedx.com

    Index Membership:N/A
    Industry:Medical Appliances & Equipment
    Full Time Employees:222

    Business Summary 

    MiMedx Group, Inc., together with its subsidiaries, designs, manufactures, and markets products and tissue processing services in the United States. The company’s products include patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies comprise AmnioFix and EpiFix, which are tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through the company’s donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. It processes the human amniotic membrane utilizing its proprietary PURION process to produce a safe and effective implant. The company also provides CollaFix, a medical device technology platform. It supplies amniotic tissue on OEM basis for application in the wound care, surgical, sports medicine, ophthalmic, and dental sectors of healthcare through direct sales force, independent sales representatives, and distributors, as well as through private label or OEM relationships. The company is headquartered in Marietta, Georgia.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on MiMedx Group, Inc.

    Corporate Governance 
    MiMedx Group, Inc.’s ISS Governance QuickScore as of Jan 1, 2015 is 10. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 6; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Parker H. Petit , 76
    Chairman and Chief Exec. Officer
    Mr. William Charles Taylor , 46
    Pres, Chief Operating Officer and Director
    Mr. Michael J. Senken , 57
    Chief Financial Officer, Principal Accounting Officer and VP
    Ms. Roberta L. McCaw , 59
    VP, Gen. Counsel and Consultant
    Dr. Thomas J. Koob Ph.D., 66
    Exec. VP and Chief Scientific Officer
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders